REG-Biotech Grw Tst PLC: Director/PDMR Shareholding

Biotech Growth TrustAnnouncement

14/06/2022 12:00

Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them

 1                         Details of the person discharging managerial responsibilities / person closely associated                                                                                                             
 a)                        Name                                                                                               Roger Yates                                                                                        
 2                         Reason for the notification                                                                                                                                                                           
 a)                        Position/status                                                                                    Non-executive Director                                                                             
 b)                        Initial notification /Amendment                                                                    Initial notification                                                                               
 3                         Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor                                                                                         
 a)                        Name                                                                                               The Biotech Growth Trust PLC                                                                       
 b)                        LEI                                                                                                549300Z41EP32MI2DN29                                                                               
 4                         Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted     
 a)                        Description of the financial instrument, type of instrument  Identification code                   Ordinary 25p shares   GB0000385517                                                                 
 b)                        Nature of the transaction                                                                          Acquisition of Shares                                                                              
 c)                        Price(s) and volume(s)                                                                                                                                                                                
 Price(s)                  Volume(s)                                                                                          
 777.6382 pence per share  10,000                                                                                             
 d)                        Aggregated information   - Aggregated volume   - Price                                             10,000 ordinary 25p shares   777.6382 pence per share                                              
 e)                        Date of the transaction                                                                            14 June 2022                                                                                       
 f)                        Place of the transaction                                                                           London Stock Exchange (XLON)                                                                       

Name of authorised official of issuer responsible for making notification:

Katherine Manson, for and on behalf of Frostrow Capital LLP

Company Secretary to THE BIOTECH GROWTH TRUST PLC



Copyright (c) 2022 PR Newswire Association,LLC. All Rights Reserved